Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Rockwell Med ( (RMTI) ) has issued an announcement.
On May 12, 2025, Rockwell Medical, Inc. released an updated corporate presentation. This update is part of their ongoing efforts to provide stakeholders with current information, although it is not intended to be filed under the Securities Exchange Act of 1934.
The most recent analyst rating on (RMTI) stock is a Buy with a $6.0000 price target. To see the full list of analyst forecasts on Rockwell Med stock, see the RMTI Stock Forecast page.
Spark’s Take on RMTI Stock
According to Spark, TipRanks’ AI Analyst, RMTI is a Neutral.
Rockwell Med achieves a score of 48, reflecting revenue growth and improved financial stability. However, the loss of a major customer and projected revenue decline pose significant challenges. Technical analysis suggests caution, and valuation metrics highlight concerns due to negative earnings. The company’s strategic initiatives offer potential but carry execution risks.
To see Spark’s full report on RMTI stock, click here.
More about Rockwell Med
Average Trading Volume: 246,001
Technical Sentiment Signal: Sell
Current Market Cap: $38.28M
See more insights into RMTI stock on TipRanks’ Stock Analysis page.